1. Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues
   Wenlong Chen et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef
2. Glycolysis: an emerging regulator of osteoarthritis
   Dingming Jiang et al, 2024, Frontiers in Immunology CrossRef
3. In Vitro Effects of Weissella cibaria CMU and CMS1 on Receptor Activator of NF-κB Ligand (RANKL)-Induced Osteoclast Differentiation
   Geun-Yeong Park et al, 2024, Journal of Functional Biomaterials CrossRef
4. D-alanine suppressed osteoclastogenesis derived from bone marrow macrophages and downregulated ERK/p38 signalling pathways
   Xiaochi Chang et al, 2024, Archives of Oral Biology CrossRef
5. Stevioside protects primary articular chondrocytes against IL-1β-induced inflammation and catabolism by targeting integrin
   Junlai Wan et al, 2023, International Immunopharmacology CrossRef
6. The Effect of Grape Seed Extract on the Alveolar, Jaw, and Skeletal Bone Remodeling: A Scoping Review
   Erdiarti Dyah Wahyuningtyas et al, 2024, European Journal of Dentistry CrossRef
7. Anemoside B4 attenuates RANKL-induced osteoclastogenesis by upregulating Nrf2 and dampens ovariectomy-induced bone loss
   Zhen Cao et al, 2023, Biomedicine & Pharmacotherapy CrossRef
8. Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
   Tao Yu et al, 2024, In Vitro Cellular & Developmental Biology - Animal CrossRef
9. Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo
   Zhihui Kuang et al, 2023, International Immunopharmacology CrossRef
10. Cilengitide inhibits osteoclast adhesion through blocking the αvβ3-mediated FAK/Src signaling pathway
    Dan-yang Guo et al, 2023, Heliyon CrossRef
11. Inhibition of CX3CL1 by treadmill training prevents osteoclast-induced fibrocartilage complex resorption during TBI healing
    Xiao Liu et al, 2024, Frontiers in Immunology CrossRef
12. Elucidation of the Key Therapeutic Targets and Potential Mechanisms of Marmesine against Knee Osteoarthritis via Network Pharmacological Analysis and Molecular Docking
    Hanbing Song et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
13. Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathways
    Fan Yang et al, 2023, International Journal of Molecular Medicine CrossRef
14. Tereticornate A suppresses RANKL-induced osteoclastogenesis via the downregulation of c-Src and TRAF6 and the inhibition of RANK signaling pathways
    Titi Liu et al, 2022, Biomedicine & Pharmacotherapy CrossRef